Cerapedics develops and commercializes peptide-enhanced bone grafts for orthopedic and spine procedures. Its flagship product, i-FACTOR Peptide Enhanced Bone Graft, combines a small P-15 peptide attached to anorganic bone mineral (ABM) to mimic the way autograft bone heals, promoting safe and predictable bone formation. The company differentiates itself by offering a biologically guided graft that relies on clinical data to support safety and efficacy, reducing the need for autograft harvest. Cerapedics aims to improve patient outcomes by providing clinicians with evidence-based graft solutions that enhance bone healing and fusion in bone grafting procedures.
Company Size
51-200
Company Stage
Late Stage VC
Total Funding
$150.9M
Headquarters
Westminster, Colorado
Founded
2000
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?